Skip to content

Corporate crypto merger

Sonnet BioTherapeutics Merges with Rorschach to Form $888M Crypto Entity Hyperliquid Strategies

Sonnet BioTherapeutics and Rorschach have finalized a merger resulting in the creation of Hyperliquid Strategies Inc. (HSI), a new entity valued at approximately $888 million. This strategic consolidation marks a significant pivot into the cryptocurrency sector for the combined organization.… Read More »Sonnet BioTherapeutics Merges with Rorschach to Form $888M Crypto Entity Hyperliquid Strategies